Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19-Reference-Cited by-同舟云学术

Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19

Published:2022-09 Issue:5 Volume:22 Page:403-408
ISSN:1470-2118
Container-title:Clinical Medicine
language:en
Short-container-title:Clin Med

Author:

Lerner Reut Kassif,Lotan Dor,Oren Daniel,Itelman Edward,Neeman Yuval,Dekel Shahar,Heller Eyal,Abu-Much Arsalan,Shilo Noya,Gilead Rami,Hubara Evyatar,Mouallem Meir,Haviv Yael,Kogan Alexander,Mayan Haim,Pessach Itai M

Publisher

Royal College of Physicians

Subject

General Medicine

Reference23 articles.

1. World Health Organization . WHO Coronavirus (COVID-19) Dashboard. WHO. https://covid19.who.int [Accessed 15 April 2022].

2. Liu X , Zhang X , Xiao Y . Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment. medRxiv 2020.04.23.20076851.

3. Hematological findings and complications of COVID ‐19

4. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!;Therapies;2023-09

2. Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?;Therapies;2023-09

3. Unwelcome guests: infectious disease beyond the pandemic;Clinical Medicine;2022-09